UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012737
Receipt number R000014883
Scientific Title Pilot study of the effect of nutritional intervention with elemental diet during chemotherapy for head and neck cancer.
Date of disclosure of the study information 2013/12/31
Last modified on 2016/05/17 10:59:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Pilot study of the effect of nutritional intervention with elemental diet during chemotherapy for head and neck cancer.

Acronym

Pilot study of nutritional intervention in chemotherapy for head and neck cancer.

Scientific Title

Pilot study of the effect of nutritional intervention with elemental diet during chemotherapy for head and neck cancer.

Scientific Title:Acronym

Pilot study of nutritional intervention in chemotherapy for head and neck cancer.

Region

Japan


Condition

Condition

Head and neck cancer

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate significance of nutritional intervention with elemental diet in the patient during chemotherapy for head and neck cancer.

Basic objectives2

Pharmacodynamics

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Change of nutritional status during chemotherapy, serum rapid turnover protein and CRP

Key secondary outcomes

1)Physical examination, blood biochemistries
2)Adverse events


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Elemental diet (300kcal/day) administration for at least 2 weeks from start of chemotherapy

Interventions/Control_2

No administration of elemental diet

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Patients with head and neck cancer who will undergo chemotherapy.
2.Patient age at the time of obtaining informed consent is 20 years of age or older.
3.Written informed consent.

Key exclusion criteria

1.Concurrent radiaon therapy.
2.Past history of serious drug hypersensitivity.
3.Severe diabetes or possibility of glucose metabolism abnormality due to high-dose steroid treatment.
4.Abnormality in amino acid metabolism.
5.Pregnant or nursing women and those with the possibility of pregnancy.
6.Participation judged by physician to be inadvisable.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kiyoaki Tsukahara

Organization

Tokyo Medical University Hachioji Medical Center

Division name

Otorhinoryngology, Head and Neck surgery

Zip code


Address

1163 Taktemachi Hachioji-shi Tokyo

TEL

042-665-5611

Email

tsuka@tokyo-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kiyoaki Tsukahara

Organization

Tokyo Medical University Hachioji Medical Center

Division name

Otorhinoryngology, Head and Neck surgery

Zip code


Address

1163 Taktemachi Hachioji-shi Tokyo

TEL

042-665-5611

Homepage URL


Email

tsuka@tokyo-med.ac.jp


Sponsor or person

Institute

Tokyo Medical University Hachioji Medical Center

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京医科大学八王子医療センター(東京都)


Other administrative information

Date of disclosure of the study information

2013 Year 12 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 08 Month 28 Day

Date of IRB


Anticipated trial start date

2013 Year 09 Month 02 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 12 Month 31 Day

Last modified on

2016 Year 05 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014883


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name